Close Menu

A biotech company called Brainstorm Cell Therapeutics may be the first to offer terminally ill patients an unproven therapy under the recently passed "right-to-try" bill — for a high price, Bloomberg reports.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.